the e-cigarettes are the most commonly used drugs in the world. however, the effectiveness of cytisinicline is not well understood. we have recently announced the development of cytisinicline in the e-cigarettes trial and we have discussed the results of the trial and the development of cytisinically administered cytisinicline. we discuss the main issues discussed in this quarter and discuss the current progress in our phase 3 trial designs.